85-1450-56 [取扱停止]Herpes Type 8, Mosaic, Recombinant (HHV8, Kaposi's Sarcoma-associated Herpes Virus) 100ug H2034-27
特徴
- E.coli derived recombinant. The protein contains the C-terminal immunodominant regions from ORF65 (aa140-170) and N-terminal regions from ORF8 (aa32-62).
- Immunoreactive with serum of HSV-8 infected individuals.
- Applications:Suitable for use as an antigen in ELISA and Western Blot. excellent antigen for detection of HSV with minimal specificity problems. Other applications not tested.
- Storage and Stability:Aliquot to avoid repeated freezing and thawing. Store at -20°C. Aliquots are stable for 6 months after receipt at -20°C. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Further dilutions can be made in assay buffer.
仕様
- Size:100ug
- Source Antigen:Recombinant, E. coli
- Grade:Highly Purified
- Purity:≥95% as determined by RP-HPLC, anion-exchange FPLC and/or reducing and non-reducing SDS-PAGE Silver Stained gel, 10% PAGE (Coomassie).
- Form:Supplied as a liquid in 100mM sodium chloride, 0.1% SDS, 50% glycerol
- EU Commodity Code:30021019
- この商品は法規制を確認しておりません。(法規制によって販売できない場合もございます)
- 製品の仕様は予告なく変更になる場合がございます。最新仕様はメーカーホームページをご確認ください。
- 【試薬に関するお問合せ】
- アズワン株式会社 試薬・プロセス材料グループ
- TEL:06-6447-8641
- FAX:06-6447-8642
- E-mail:[email protected]
商品のバリエーション (サイズ違い・スペック違い・オプション品など)
よくあるご質問(FAQ)
掲載カタログ情報
| 掲載カタログ名 | 掲載ページ |
|---|





